Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-11-19 06:44 am Sale |
2021-11-16 | 13D | Trillium Therapeutics Inc. TRIL |
Growth Equity Opportunities V LLC | 0 0.000% |
-6,586,363 (Position Closed) |
Filing History |
| 2021-11-15 4:35 pm Sale |
2021-11-15 | 13G | Trillium Therapeutics Inc. TRIL |
RA Capital Management, L.P. | 0 0.000% |
-5,290,481 (Position Closed) |
Filing History |
| 2021-08-31 6:43 pm Unchanged |
2021-08-20 | 13D | Trillium Therapeutics Inc. TRIL |
Growth Equity Opportunities V LLC | 6,586,363 6.300% |
0 (Unchanged) |
Filing History |
| 2021-04-07 4:32 pm Unchanged |
2020-04-01 | 13G | Trillium Therapeutics Inc. TRIL |
RA Capital Management, L.P. | 5,290,481 5.100% |
0 (Unchanged) |
Filing History |
| 2021-02-16 5:17 pm Sale |
2020-12-31 | 13G | Trillium Therapeutics Inc. TRIL |
Boxer Capital LLC | 0 0.000% |
-4,425,000 (Position Closed) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Trillium Therapeutics Inc. TRIL |
RA Capital Management, L.P. | 5,290,481 5.300% |
5,290,481 (New Position) |
Filing History |
| 2021-02-16 4:11 pm Purchase |
2020-12-31 | 13G | Trillium Therapeutics Inc. TRIL |
Venrock Healthcare Capital Partners III L.P. | 4,040,000 4.000% |
1,250,000 (+44.80%) |
Filing History |
| 2021-02-12 4:30 pm Sale |
2020-12-31 | 13G | Trillium Therapeutics Inc. TRIL |
Vivo Capital IX, LLC | 0 0.000% |
-3,679,060 (Position Closed) |
Filing History |
| 2021-02-12 08:09 am Purchase |
2020-12-31 | 13G | Trillium Therapeutics Inc. TRIL |
AVORO CAPITAL ADVISORS LLC | 5,800,000 5.700% |
5,800,000 (New Position) |
Filing History |
| 2020-05-11 4:13 pm Sale |
2020-04-30 | 13G | Trillium Therapeutics Inc. TRIL |
MORGAN STANLEY MS |
1,243,313 1.500% |
-626,691 (-33.51%) |
Filing History |